Field evaluation of alternative testing strategies for diagnosis and differentiation of HIV-1 and HIV-2 infections in an HIV-1 and HIV-2-prevalent area

AIDS

Volumn 11, Issue 15, 1997, Pages 1815-1822

  Andersson, Sören ^a,c   Da Silva, Zacarias ^b   Norrgren, Hans ^a   Dias, Francisco ^b   Biberfeld, Gunnel ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b National Public Health Laboratory   (Guinea-Bissau)

^c SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

Author keywords

Africa; Alternative confirmatory strategies; Differentiation; Dual reactivity; Enzyme linked immunosorbent assay; Guinea Bissau; HIV antibody testing; HIV 1; HIV 2; Rapid simple tests

Indexed keywords

ARTICLE; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; GUINEA-BISSAU; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; IMMUNOASSAY; IMMUNOBLOTTING; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SCREENING TEST; VIRUS DIAGNOSIS;

EID: 0030726870     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199715000-00005     Document Type: Article

References (35)

1. Constantine NT: Serologic tests for the retroviruses: approaching a decade of evolution. AIDS 1993, 7:1-13.
2. Mortimer PP: The fallibility of HIV Western blot. Lancet 1991, 337:286-287.
3. Midthun K, Garrison L, Clements ML, et al.: Frequency of indeterminate Western blot tests in healthy adults at low risk for human immunodeficiency virus infection. J Infect Dis 1990, 162:1379-1382.
4. Simon F, Pepin JM, Brun-Vézinet F, Bouchaud O, Casalino H, Gérard L: Reliability of Western blotting for the confirmation of HIV-1 seroconversion. Lancet 1992, 340:1541-1542.
5. Walther L, Putkonen P, Dia F, Biberfeld G, Thorstensson R: Evaluation of HIV-1/HIV-2 immunoblots for detection or HIV-2 antibodies. Clin Diagn Virol 1995, 4:67-69.
6. Spielberg F, Mulanga Kabeya C, Quinn T, et al.: Performance and cost-effectiveness of a dual rapid assay system for screening and confirmation of human immunodeficiency virus type 1 seropositivity. J Clin Microbiol 1990, 28:303-306.
7. Fonseca K, Anand C: Predicting human immunodeficiency virus type 1-positive sera by using enzyme immunoassay kits in a parallel testing format. J Clin Microbiol 1991, 29:2597-2612.
8. Mitchell S, Mboup S, Mingle J, et al.: Field evaluation of alternative HIV testing strategy with a rapid immunobinding assay and an agglutination assay. Lancet 1991, 337:1328-1331.
9. van der Groen G, van Kerckhoven I, Vercauteren G, Piot P: Simplified and less expensive confirmatory HIV testing. Bull WHO 1991, 69:747-752.
10. Behets F, Bishagara K, Disasi A, et al.: Diagnosis of HIV infection with instrument-free assays as an alternative to the ELISA and Western blot testing strategy: an evaluation in Central Africa. J Acquir Immune Defic Syndr 1992, 5:878-882.
11. Nkengasong J, van Kerckhoven I, Vercauteren G, Piot P, van der Groen G: Alternative confirmatory strategy for anti-HIV antibody detection. J Virol Methods 1992, 36:159-170.
12. Mortimer J: An alternative approach to confirming anti-HIV reactivity: a multi-country collaborative study. Bull WHO 1992, 70:751-756.
13. Urassa W, Bredberg-Radën U, Mbena E, et al.: Alternative confirmatory strategies in HIV-1 antibody testing. J Acquir Immune Defic Syndr 1992, 5:170-176.
14. Nunn AJ, Biryahwaho B, Downing RG, van der Groen G, Ojwiya A, Mulder DW: Algorithms for detecting antibodies to HIV-1: results from a rural Ugandan cohort. AIDS 1993, 7:1057-1061.
15. Urassa W, Matunda S, Bredberg-Raden U, Mhalu L, Biberfeld G: Evaluation of the WHO human immunodeficiency virus (HIV) antibody testing strategy for the diagnosis of HIV infection. Clin Diagn Virol 1994, 2:1-6.
16. Thorstensson R, Gaines H, Biberfeld G: Large-scale evaluation of an alternative strategy for confirmation of HIV antibodies. Clin Diagn Virol 1995, 4:15-25.
17. Ittiravivongs A, Likanonsakul S, Mastro L, et al.: Evaluation of a confirmatory HIV testing strategy in Thailand not using Western blot. J Acquir Immune Defic Syndr 1996, 13:296-297.
18. Carvalho MB, Hamerschlak N, Vaz RS, Ferreira Jr OC: Risk factor analysis and serological diagnosis of HIV-1/HIV-2 infection in a Brazilian blood donor population: validation of the World Health Organization strategy for HIV testing. AIDS 1996, 10:1135-1140.
19. Stetler HC, Granade IC, Nunez CA, et al.: Field evaluation of rapid HIV serologic tests for screening and confirming HIV-1 infection in Honduras. AIDS 1997, 11:369-375.
20. Wilkinson D, Wilkinson NE, Lombard C, et al.: On-site HIV testing in resource-poor settings: is one rapid test enough? AIDS 1997, 11:377-381.
21. Tamashiro M, Maskill W, Immanuel J, et al.: Reducing the cost of HIV antibody testing. Lancet 1993, 342:87-90.
22. Sato P, Maskill W, Tamashiro H, Heymann D: Strategies for laboratory HIV testing: an examination of alternative approaches not requiring Western blot. Bull WHO 1994, 72:129-134.
23. Nauclér A, Andersson S, Albino P, Paolo Da Silva A, Andreasson P-A, Biberfeld G: Association between HTLV-1 and HIV-2 infections in Bissau, Guinea-Bissau [letter]. AIDS 1992, 6:510-511.
24. Poulsen A-C, Kvinsedal B, Aaby P, et al.: Prevalence of and mortality from human immunodeficiency virus type 2 in Bissau, West Africa. Lancet 1989, i:827-830.
25. Norrgren H, Andersson S, Nauclér A, Dias L, Johansson I, Biberfeld G: HIV-1, HIV-2, HTLV-I/II and Treponema pallidum infections: incidence, prevalence and HIV-2 associated mortality in an occupational cohort in Guinea-Bissau. J Acquir Immune Defic Syndr 1995, 9:422-428.
26. Nauclér A, Albino P, Paolo Da Silva A, Andreasson P-A, Andersson S, Biberfeld G: HIV-2 infection in hospitalized patients in Bissau, Guinea-Bissau. AIDS 1991, 5:301-304.
27. Albert J, Bredberg U, Chiodi L, et al.: A new human retrovirus isolate of West African origin (SBL-6669) and its relationship to HTLV-IV, LAV-II and HTLV-IIIB. AIDS Res Hum Retroviruses 1987, 3:3-10.
28. WHO Global Programme on AIDS: Proposed WHO criteria for interpretation of results from Western blot assay for HIV-1, HIV-2 and HTLV-I/HTLV-II. WHO Epidemiol Rec 1990, 37:281-283.
29. De Cock KM, Porter A, Kouadio J, et al.: Cross-reactivity on Western blots in HIV-1 and HIV-2 infections. AIDS 1991, 5:859-863 [Erratum AIDSt; 1991, 5:following 1155].
30. Anonymous: Geigy Scientific Tables Vol. 2 Basel: CIBA-Geigy; 1982.
31. Brown R, Swanson Beck J (Eds): Medical Statistics on Microcomputers, London: BMJ; 1990.
32. Kline R, Dada A, Blattner W, Quinn I: Diagnosis and differentiation of HIV-1 and HIV-2 infection by two rapid assays in Nigeria. J Acquir Immune Defic Syndr 1992, 36:159-170.
33. Brattegard K, Kouadio J, Adom M-L, Doorly R, George RJ, De Cock KM: Rapid and simple screening and supplemental testing for HIV-1 and HIV-2 infections in West Africa. AIDS 1993, 7:833-885.
34. Parekh BS, Pau C-P, Granade IC et al.: Oligomeric nature of transmemhrane glycoproteins of HIV-2: procedures for their efficient dissociation and preparation of Western blots for diagnosis. AIDS 1991, 5:1009-1013.
35. Andersson S, Dias F, Norrgren H, Biberfeld G: Evaluation of an alternative strategy for confirmation of HIV infection in an HIV-2 endemic country. VIII International Conference on AIDS in Africa. Marrakech. December 1993 [abstract ThRT015].